SCHEMBL29263345

SCHEMBL29263345

O=C(Nc1nc2ccccc2s1)c1ccc(C(=O)N2CCN(C(=O)Nc3ccccc3F)CC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.59
▸ RAB9A P51151 6/20 0.59
▸ KDM4E B2RXH2 3/20 0.59
▸ NFKB1 P19838 1/20 0.59
▸ HTT P42858 1/20 0.59
▸ NFKB2 Q00653 1/20 0.59
▸ RELA Q04206 1/20 0.59
▸ MEN1 O00255 4/20 0.55
▸ KMT2A Q03164 4/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ LRRK2 Q5S007 1/20 0.54
▸ SCD O00767 6/20 0.54
▸ MAPT P10636 1/20 0.52
▸ TRPV1 Q8NER1 1/20 0.52
▸ HPGDS O60760 3/20 0.50
▸ TOP1 P11387 2/20 0.50
▸ MMP13 P45452 1/20 0.50
▸ HPGD P15428 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30576805 0.88 FAAH (0.60) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL26606499 0.88 FAAH (0.60) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL29263362 0.87 KDM4E (0.54) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL29263366 0.86 NPC1 (0.69) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL29263354 0.86 NPC1 (0.62) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL29263370 0.83 KDM4E (0.56) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL29263330 0.82 ADORA2A (0.58) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL29263337 0.82 NPC1 (0.55) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL29263341 0.82 NPC1 (0.57) NPC1RAB9AKDM4ENFKB1HTT
SCHEMBL29263334 0.80 NPC1 (0.58) NPC1RAB9AKDM4ENFKB1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116829542-A Benzothiazole and benzimidazole derivatives, pharmaceutically acceptable salts, preparation method thereof and pharmaceutical composition containing same as active ingredient 韩国化学研究院 2023-09-29 — — CN disclosed
Send feedback